The move marks Italy’s Angelini Pharma’s entry into the U.S. market.
Source link
Catalyst Pharma to Be Acquired by Angelini Pharma in $4.1 Billion Deal
Date:
More like thisRelated
Kid Rock Says Trump Support Cost Him Hollywood Opportunities
Kid Rock says his support for President Donald Trump...
Bloom Energy Lifts Outlook, Logs Higher Profit
The company now expects full-year adjusted earnings of between...
Stephen Hubbard returns to U.S. after Russian detention
Stephen Hubbard, an American who'd been detained by Russia...